Prognostic factors in AML in relation to (ab)normal karyotype-Reference-Cited by-同舟云学术

Prognostic factors in AML in relation to (ab)normal karyotype

Published:2009-12 Issue:4 Volume:22 Page:523-528
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Stone Richard M.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference41 articles.

1. Genetics of myeloid malignancies: pathogenetic and clinical implications;Frohling;J Clin Oncol,2005

2. A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes;Ley;Proc Natl Acad Sci U S A,2003

3. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties;Grimwade;Blood,1998

4. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype;Bloomfield;Cancer Res,1998

5. Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B;Frohling;Blood,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A drug–biomarker interaction model to predict the key targets of Scutellaria barbata D. Don in adverse-risk acute myeloid leukaemia;Molecular Diversity;2020-07-16

2. Variant allele frequencies do not correlate well with myeloblast counts in a clinically validated gene sequencing panel for routine acute myeloid leukemia workup;Leukemia & Lymphoma;2019-04-18

3. Vitamin D and Leukaemia;Extraskeletal Effects of Vitamin D;2018

4. Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia;Oncology Letters;2017-07-28

5. Analysis of the presence of FLT3 gene mutation and association with prognostic factors in adult and pediatric acute leukemia patients;Brazilian Journal of Pharmaceutical Sciences;2017